Alma Bio Therapeutics
  • Home
  • About Us
    • About Us
    • The People
  • Our Approach
    • Autoimmune Diseases
    • Our Therapeutic Approach
  • Pipeline
  • News
  • Contact Us

News

Alma Bio Therapeutics will present at the French-Israeli joint healthcare event in Paris

  • Dan Gelvan
  • November 17, 2019
  • News
  • 0 Comments

December 2019 - Alma Bio Therapeutics will be attending the French-Israeli joint event in the healthcare sector, Paris December 10, 2019, sponsored by the BPI, the French Public Investment Bank. As part…

Continue Reading

Alma will present at the EIT Health Summit 2019

  • Dan Gelvan
  • November 17, 2019
  • News
  • 0 Comments

December 2019  - Alma has been invited to present at the EIT Health Summit 2019, December 2-3 Paris. Come and meet us there.

Continue Reading

Alma receives the EMA’s scientific advice for its lead product

  • Dan Gelvan
  • November 17, 2019
  • News
  • 0 Comments

October 2019 -  Alma receives the EMA's CHMP (Committee for Medicinal Products for Human Use) scientific advice. The Agency's advice concerned quality development, pre-clinical development and clinical development for the…

Continue Reading

Alma is featured in Cello Health BioConsulting’s panel on autoimmune diseases

  • Dan Gelvan
  • November 17, 2019
  • News
  • 0 Comments

August 2019 - Alma is featured in Cello Health BioConsulting's "Next-generation-therapies-for-autoimmune-and-inflammatory-diseases". Alma is listed among the "next generation approaches in development with novel targets and modalities"

Continue Reading

Alain P. Rolland joins Alma’s scientific advisory board

  • Dan Gelvan
  • November 17, 2019
  • News
  • 0 Comments

January 2019 - Alma appointed Dr. Alain P. Rolland to serve on its scientific advisory board. Dr. Rolland's appointment will strengthen Alma's capacities in the fields of DNA drugs and…

Continue Reading

Health Investor Day

  • Agnes
  • September 4, 2019
  • News
  • 0 Comments

Dr Binah Baum, Alma Bio Therapeutics CEO, was at the Health Investor Day in Paris on June 24th-25th, 2019.

Continue Reading

JP Morgan Healthcare Investor Conference 2019

  • Liad
  • November 12, 2018
  • News

We were at the 37th annual JP Morgan Healthcare Investor Conference in San Francisco, CA from January 7th-10th, 2019

Continue Reading

Recent Posts

  • Alma Bio Therapeutics will present at the French-Israeli joint healthcare event in Paris
  • Alma will present at the EIT Health Summit 2019
  • Alma receives the EMA’s scientific advice for its lead product
  • Alma is featured in Cello Health BioConsulting’s panel on autoimmune diseases
  • Alain P. Rolland joins Alma’s scientific advisory board

Questions? Contact Us!

Site Navigation

  • Home
  • About Us
  • Our Approach
  • Pipeline
  • News

Contact Info

  • ALMA BIO THERAPEUTICS
  • 317 Ave Jean Jaures
    Lyon 69007 France
  • +33 4 37 66 47 49
  • contact@alma-bio.com
© All Right Reserved to Alma Bio Therapeutics 2018